Ipksindia May 2026

She was testing a batch of a common antimalarial drug, Artesunate, sent from a manufacturer in Nagpur. The label claimed it contained 500 mg of active ingredient. The machine said 120 mg. The rest was cheap fillers—chalk, starch, and a nasty binder that could cause kidney failure.

She volunteered to join the inspection team. They drove eight hours to Nagpur, to the “Shree Pharma” factory. The owner, a portly man named Mr. Mehta, met them with sweet tea and a wide, oily smile. ipksindia

As the locks clicked shut on Shree Pharma, Ananya thought about the quiet, nerdy work of the IPC. While the world chased flashy new drugs, she and her colleagues were the silent guardians. They wrote the rules. They defined what “pure” meant. They turned a thousand-page book into a shield. She was testing a batch of a common

But Ananya knew that the real battle wasn't in the lab. It was on the road. The rest was cheap fillers—chalk, starch, and a

Back in her office the next morning, a new email arrived. A manufacturer in Hyderabad had submitted a new generic antibiotic for monograph inclusion. It was a life-saving drug for drug-resistant tuberculosis.

Mr. Mehta’s smile vanished. “We have political connections. This will go away.”